Equities research analysts expect Medical Transcription Billing Corp (NASDAQ:MTBC) to report ($0.18) earnings per share for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Medical Transcription Billing’s earnings. The highest EPS estimate is ($0.15) and the lowest is ($0.21). Medical Transcription Billing reported earnings per share of $0.13 during the same quarter last year, which suggests a negative year over year growth rate of 238.5%. The company is expected to announce its next quarterly earnings results on Wednesday, March 6th.
On average, analysts expect that Medical Transcription Billing will report full year earnings of ($0.50) per share for the current financial year, with EPS estimates ranging from ($0.61) to ($0.38). For the next financial year, analysts forecast that the business will report earnings of ($0.20) per share, with EPS estimates ranging from ($0.27) to ($0.13). Zacks’ earnings per share calculations are a mean average based on a survey of research analysts that that provide coverage for Medical Transcription Billing.
Medical Transcription Billing (NASDAQ:MTBC) last posted its quarterly earnings data on Wednesday, November 7th. The technology company reported ($0.25) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.23) by ($0.02). The company had revenue of $17.05 million for the quarter, compared to analysts’ expectations of $16.66 million. Medical Transcription Billing had a negative net margin of 6.62% and a negative return on equity of 8.26%.
Separately, HC Wainwright set a $6.00 price objective on shares of Medical Transcription Billing and gave the company a “buy” rating in a research report on Thursday, November 8th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Medical Transcription Billing has a consensus rating of “Buy” and an average target price of $3.92.
In related news, General Counsel Shruti H. Patel sold 12,291 shares of the stock in a transaction on Wednesday, September 12th. The shares were sold at an average price of $4.61, for a total transaction of $56,661.51. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO Bill Korn sold 9,664 shares of the stock in a transaction on Wednesday, November 7th. The shares were sold at an average price of $5.52, for a total transaction of $53,345.28. Following the transaction, the chief financial officer now directly owns 167,750 shares in the company, valued at approximately $925,980. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 52,760 shares of company stock worth $267,050. 49.70% of the stock is owned by insiders.
Several hedge funds have recently added to or reduced their stakes in the stock. Virtu Financial LLC bought a new position in shares of Medical Transcription Billing during the 3rd quarter valued at $101,000. Macquarie Group Ltd. grew its holdings in shares of Medical Transcription Billing by 59.6% during the 2nd quarter. Macquarie Group Ltd. now owns 100,401 shares of the technology company’s stock valued at $389,000 after purchasing an additional 37,501 shares during the last quarter. Finally, Dimensional Fund Advisors LP bought a new position in shares of Medical Transcription Billing during the 2nd quarter valued at $108,000. 5.52% of the stock is currently owned by institutional investors.
Shares of Medical Transcription Billing stock traded down $0.23 on Friday, hitting $4.70. 52,720 shares of the company traded hands, compared to its average volume of 74,770. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.65 and a current ratio of 1.70. The stock has a market cap of $58.32 million, a P/E ratio of -36.15 and a beta of 1.57. Medical Transcription Billing has a 12-month low of $2.53 and a 12-month high of $5.65.
Medical Transcription Billing Company Profile
Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.
Featured Article: What are trading strategies for the 52-week high/low?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Medical Transcription Billing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing and related companies with MarketBeat.com's FREE daily email newsletter.